Immune Therapeutics, Inc.
IMUN · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $21,774 | $1,446 | $6,692 | $2,909 |
| - Cash | $150 | $494 | $10 | $5 |
| + Debt | $696 | $3,070 | $2,845 | $5,545 |
| Enterprise Value | $22,320 | $4,023 | $9,527 | $8,449 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$643 | $1,907 | -$1,060 | -$2,454 |
| % Margin | – | – | – | – |
| Net Income | -$5,788 | $3,586 | $1,109 | -$4,673 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.16 | 0.38 | 2.4 | -10.44 |
| % Growth | -142.1% | -84.2% | 123% | – |
| Operating Cash Flow | -$582 | -$232 | -$192 | -$1 |
| Capital Expenditures | -$500 | $0 | $0 | $0 |
| Free Cash Flow | -$1,082 | -$232 | -$192 | -$1 |